Your browser doesn't support javascript.
loading
Oncological outcomes after simple and skin-sparing mastectomy of ductal carcinoma in situ: A register-based cohort study of 576 Norwegian women.
Skjerven, Helle Kristine; Myklebust, Even Moa; Korvald, Christian; Porojnicu, Alina Carmen; Kaaresen, Rolf; Hofvind, Solveig; Schlicting, Ellen; Sahlberg, Kristine Kleivi.
Afiliação
  • Skjerven HK; Section for Breast and Endocrine Surgery, Drammen Hospital, Vestre Viken Hospital Trust, Drammen, Norway; Faculty of Medicine, University of Oslo, Oslo, Norway. Electronic address: Helle.skjerven@vestreviken.no.
  • Myklebust EM; Oslo Centre for Biostatistics and Epidemiology, Faculty of Medicine, University of Oslo, Oslo, Norway; Department of Research and Innovation, Vestre Viken Hospital Trust, Drammen, Norway.
  • Korvald C; Department of Plastic and Reconstructive Surgery, Oslo University Hospital, Oslo, Norway.
  • Porojnicu AC; Section for Oncology, Drammen Hospital, Vestre Viken Hospital Trust, Drammen, Norway.
  • Kaaresen R; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Hofvind S; Department of Health and Care Sciences, The Artic University, UiT, Tromsø, Norway; Section for Breast Cancer Screening, Cancer Registry of Norway, Oslo, Norway.
  • Schlicting E; Section for Breast and Endocrine Surgery, Oslo University Hospital, Oslo, Norway.
  • Sahlberg KK; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Research and Innovation, Vestre Viken Hospital Trust, Drammen, Norway.
Eur J Surg Oncol ; 49(3): 575-582, 2023 03.
Article em En | MEDLINE | ID: mdl-36509629
BACKGROUND: For Ductal Carcinoma in Situ (DCIS), recurrence is shown to be higher after skin-sparing (SSM) versus simple (SM) mastectomy. This study aimed to compare the two groups recurrence rates, disease-free survival (DFS), and overall (OS) survival. METHODS: We conducted a retrospective register-based cohort study of women operated with SSM (n = 338) or SM (n = 238) for DCIS between 2007 and 2017. Data from the Norwegian Breast Cancer Registry was used to estimate recurrences rates, DFS and OS. RESULTS: Mean age was 51 and 61 years in the SSM and SM groups, respectively. Median follow-up time was 77 months for SSM (range: 21-152 months) vs 84 months for SM (range: 7-171 months). After five years of follow-up, the overall recurrence rate (OR) was 2.1%; 3.9% for SSM and 0.9% for SM. After ten years, the rates were 3.0%, 6.2% for SSM and still 0.9% for SM. DFS was after ten years 92.2%; 91.8% for SSM, and 92.4% for SM. OS was 95.0%; 97.5% for SSM and 93.3% for SM at ten years. For SSM, involved margins represented a significant risk for recurrence. CONCLUSION: The recurrence rate was higher in the SSM versus the SM group. Whether the difference is due to the operating procedures or underlying risk factors remains unknown. When stratifying for the difference in age, there was no statistical difference in DFS or OS. Involved margins in the SSM group were associated with an increased risk of recurrence.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Mamoplastia / Carcinoma Ductal de Mama / Carcinoma Intraductal não Infiltrante Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Mamoplastia / Carcinoma Ductal de Mama / Carcinoma Intraductal não Infiltrante Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2023 Tipo de documento: Article